期刊文献+

PDCA循环法在注射用英夫利西单抗输注管理中的应用效果 被引量:2

下载PDF
导出
摘要 运用PDCA循环法进行注射用英夫利西单抗输注管理,比较管理实施前后的输注执行规范率、护理人员相关知识考核成绩以及患者对护士的护理满意度。实施PDCA循环管理后评估规范率、配制规范率、输注规范率、记录规范率、宣教规范率、总体执行规范率均高于实施前;护士考核成绩总分(91.07±3.20)分,显著优于实施前的(76.53±4.22)分;患者满意度实施后97%,高于实施前的90%,比较差异均有统计学意义(P<0.05)。PDCA循环管理能有效提高注射用英夫利西单抗输注的护理质量。
作者 郑军 朱芳芳
出处 《护理与康复》 2020年第6期64-67,共4页 Journal of Nursing and Rehabilitation
  • 相关文献

参考文献10

二级参考文献95

  • 1王吉耀.内科学[M].北京:人民卫生出版社,2003.884.
  • 2D' Haens GR. Infliximab as disease-modifying therapy[ J]. Eur J Gastroenterol Hepatol,2003,15 (3) :233-237.
  • 3尤黎明.实用内科学[M].12版.北京:人民卫生出版社,2006:457.
  • 4Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn ' s disease: results from a single-centre cohort [ J ]. Gut,2009,58 (4) :492-500.
  • 5Kraemer M, Kirschmeier A, Marth T. Perioperative adjuvant therapy with infliximab in complicated anal Crohn' s disease [ J ]. Int J Colorectal Dis,2008,23 (10) :965-969.
  • 6Dougados M, Betteridge N, Burmester GR, et al. EULAR stan-dardised operating procedures for the elaboration, evaluation, dissemination, and implementation of recommendations endorsed by the EULAR standing committees [J]. Ann Rheum Dis, 2004, 63: 1172-1176. DOI: 10.1136/annrheumdis-2013-204733.
  • 7Smolen JS, Landew6 R, Breedveld FC, et al. EULAR recom- mendations for the management of rheumatoid arthritis with syn- thetic and biological disease-modifying antirheumatic drugs: 2013 update [J]. Ann Rheum Dis, 2014, 73: 492-509. DOI: 10.1136/annrheumdis-2013-204573.
  • 8Miehsler W, Novacek G, Wenzl H, et al. A decade of inflix- imab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease [J]. J Crohns Colitis, 2010, 4: 221-256. DOI: 10.1016/i.erohns.2009.12.001.
  • 9Cheifetz A, Smedley M, Martin S, et al. The incidence and management of infusion reactions to infliximab: a large center experience[J]. Am J Gastroenterol, 2003, 98(6): 1315-1324. DOI: 10.1111/j. 1572-0241.2003.07457.x.
  • 10Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatie drugs and biologic agents in the treatment of rheumatoid arthritis[J]. Arthritis Care Res (Hoboken), 2012, 64(5):625-639.

共引文献161

同被引文献19

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部